|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bandi N, Zbinden S, Gugger M, et al:
miR-15a and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhattacharya R, Nicoloso M, Arvizo R, et
al: miR-15a and miR-16 control Bmi-1 expression in ovarian cancer.
Cancer Res. 69:9090–9095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonci D, Coppola V, Musumeci M, et al: The
miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med. 14:1271–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aqeilan RI, Calin GA and Croce CM: miR-15a
and miR-16-1 in cancer: discovery, function and future
perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsang WP and Kwok TT: Epigallocatechin
gallate up-regulation of miR-16 and induction of apoptosis in human
cancer cells. J Nutr Biochem. 21:140–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boominathan L: The tumor suppressors p53,
p63, and p73 are regulators of microRNA processing complex. PLoS
One. 5:e106152010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto
T, Kato S and Miyazono K: Modulation of microRNA processing by p53.
Nature. 460:529–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alexander D, Jhala N, Chatla C, et al:
High-grade tumor differentiation is an indicator of poor prognosis
in African Americans with colonic adenocarcinomas. Cancer.
103:2163–2170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng S, Cong S, Zhang X, et al:
MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation
and induces cell apoptosis in lung cancer cells. Nucleic Acids Res.
39:6669–6678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fabbri M, Bottoni A, Shimizu M, et al:
Association of a microRNA/TP53 feedback circuitry with pathogenesis
and outcome of B-cell chronic lymphocytic leukemia. JAMA.
305:59–67. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bottoni A, Piccin D, Tagliati F, Luchin A,
Zatelli MC and degli Uberti EC: miR-15a and miR-16-1
down-regulation in pituitary adenomas. J Cell Physiol. 204:280–285.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yip KW, Shi W, Pintilie M, et al:
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and
survivin in nasopharyngeal cancer. Clin Cancer Res. 12:5726–5732.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen W, Wang CY, Wang XH and Fu ZX:
Oncolytic adenovirus mediated Survivin knockdown by RNA
interference suppresses human colorectal carcinoma growth in vitro
and in vivo. J Exp Clin Cancer Res. 28:812009. View Article : Google Scholar
|
|
18
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kawasaki H, Toyoda M, Shinohara H, et al:
Expression of survivin correlates with apoptosis, proliferation,
and angiogenesis during human colorectal tumorigenesis. Cancer.
91:2026–2032. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lynch CJ and Milner J: Loss of one p53
allele results in four-fold reduction of p53 mRNA and protein: a
basis for p53 haplo-insufficiency. Oncogene. 25:3463–3470. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vegran F, Boidot R, Oudin C, Defrain C,
Rebucci M and Lizard-Nacol S: Association of p53 gene alterations
with the expression of antiapoptotic survivin splice variants in
breast cancer. Oncogene. 26:290–297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoffman WH, Biade S, Zilfou JT, Chen J and
Murphy M: Transcriptional repression of the anti-apoptotic survivin
gene by wild type p53. J Biol Chem. 277:3247–3257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murphy M, Ahn J, Walker KK, et al:
Transcriptional repression by wild-type p53 utilizes histone
deacetylases, mediated by interaction with mSin3a. Genes Dev.
13:2490–2501. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mirza A, McGuirk M, Hockenberry TN, et al:
Human survivin is negatively regulated by wild-type p53 and
participates in p53-dependent apoptotic pathway. Oncogene.
21:2613–2622. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raj D, Liu T, Samadashwily G, Li F and
Grossman D: Survivin repression by p53, Rb and E2F2 in normal human
melanocytes. Carcinogenesis. 29:194–201. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang X, Xiong G, Chen X, et al: Survivin
expression in esophageal cancer: correlation with p53 mutations and
promoter polymorphism. Dis Esophagus. 22:223–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suh SO, Chen Y, Zaman MS, et al:
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation
in prostate cancer. Carcinogenesis. 32:772–778. 2011. View Article : Google Scholar : PubMed/NCBI
|
